Albadrani, Muayad <br/><br/>
Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21.  [electronic resource] 

 -  American journal of physiology. Gastrointestinal and liver physiology  10 2019 
 - G408-G428 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1522-1547 
<br/><br/><label>Standard No.: </label>10.1152/ajpgi.00061.2019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD--biosynthesis<br/>Antigens, Differentiation, Myelomonocytic--biosynthesis<br/>Cytokines--metabolism<br/>Enzyme Inhibitors--toxicity<br/>Hepatic Stellate Cells--drug effects<br/>Kupffer Cells--drug effects<br/>Liver Cirrhosis--chemically induced<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>MicroRNAs--genetics<br/>Microcystins--toxicity<br/>NADPH Oxidase 2--genetics<br/>NADPH Oxidases--metabolism<br/>Non-alcoholic Fatty Liver Disease--chemically induced<br/>Peroxynitrous Acid--metabolism<br/>Protein Phosphatase 2--antagonists & inhibitors